Single User License
INR 161300
Site License
INR 322600
Corporate User License
INR 483900

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Verrucous Carcinoma Global Clinical Trials Review, H1, 2015

Verrucous Carcinoma Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2624CTIDB
  • |
  • Pages: 71
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Verrucous Carcinoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Verrucous Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Verrucous Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Verrucous Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Verrucous Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Verrucous Carcinoma 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in North America 10

Top Countries Contributing to Clinical Trials in Middle East and Africa 11

Top Countries Contributing to Clinical Trials in Central and South America 12

Clinical Trials by G7 Countries: Proportion of Verrucous Carcinoma to Oncology Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Verrucous Carcinoma to Oncology Clinical Trials 16

Clinical Trials by Phase 17

In Progress Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Unaccomplished Trials of Verrucous Carcinoma 21

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Prominent Drugs 26

Clinical Trial Profiles 27

Clinical Trial Overview of Top Companies 27

MatrixPharm 27

Clinical Trial Overview of MatrixPharm 27

Clinical Trial Overview of Top Institutes / Government 28

National Cancer Institute 28

Clinical Trial Overview of National Cancer Institute 28

Roswell Park Cancer Institute 31

Clinical Trial Overview of Roswell Park Cancer Institute 31

Fox Chase Cancer Center 32

Clinical Trial Overview of Fox Chase Cancer Center 32

Ohio State University Comprehensive Cancer Center 33

Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 33

Radiation Therapy Oncology Group 34

Clinical Trial Overview of Radiation Therapy Oncology Group 34

University of Chicago 35

Clinical Trial Overview of University of Chicago 35

Wake Forest University 36

Clinical Trial Overview of Wake Forest University 36

Abramson Cancer Center 37

Clinical Trial Overview of Abramson Cancer Center 37

AIDS Malignancy Clinical Trials Consortium 38

Clinical Trial Overview of AIDS Malignancy Clinical Trials Consortium 38

Case Comprehensive Cancer Center 39

Clinical Trial Overview of Case Comprehensive Cancer Center 39

Five Key Clinical Profiles 40

Appendix 69

Abbreviations 69

Definitions 69

Research Methodology 70

Secondary Research 70

About GlobalData 71

Contact Us 71

Disclaimer 71

Source 71

List of Figures

Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Verrucous Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Verrucous Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Verrucous Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10

Verrucous Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 11

Proportion of Verrucous Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2015* 13

Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Verrucous Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2015* 16

Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17

Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18

Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Verrucous Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Verrucous Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Verrucous Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24

Verrucous Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

GlobalData Methodology 70

List of Tables

Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Region, 2015* 6

Verrucous Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Verrucous Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Verrucous Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 10

Verrucous Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11

Verrucous Carcinoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 12

Proportion of Verrucous Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2015* 13

Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Verrucous Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2015* 16

Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2015* 17

Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18

Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Verrucous Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Verrucous Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2015* 21

Verrucous Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 21

Verrucous Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2015* 22

Verrucous Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Verrucous Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24

Verrucous Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Verrucous Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MatrixPharm, 2015* 27

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 28

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2015* 31

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015* 32

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2015* 33

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015* 34

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 35

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2015* 36

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2015* 37

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Malignancy Clinical Trials Consortium, 2015* 38

Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Verrucous Carcinoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Verrucous Carcinoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com